ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision makingHans‐Joachim Schmoll, Andrés Cervantes, Eric Van Cutsem et al.|Annals of Oncology|2012Cited by 1.5k
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trialAimery de Gramont, Paulo M. Hoff, Eric Van Cutsem et al.|The Lancet Oncology|2012Cited by 526
Sorafenib in Combination With Capecitabine: An Oral Regimen for Patients With HER2-Negative Locally Advanced or Metastatic Breast CancerJosé Baselga, Frederico Costa, Brigitte Van Eyll et al.|Journal of Clinical Oncology|2012Cited by 163
Cytokine profile and prognostic significance of high neutrophil-lymphocyte ratio in colorectal cancerZ.-Y. Chen, Scott Kopetz, Kanwal Raghav et al.|British Journal of Cancer|2015Cited by 148